Evidence map›Paper›PMID 31921405›Full record

ArticleMolecular autism2020

Biophysical classification of a

Nadja T Hofer, Petronel Tuluc, Nadine J Ortner, Yuliia V Nikonishyna, Monica L Fernándes-Quintero, Klaus R Liedl, Bernhard E Flucher, Helen Cox, Jörg Striessnig

Open access · goldAbstract read
In one paragraph

Article in Molecular autism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Identification of novel functional sites in the CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Inactivation of CaV1 and CaV2 channels.The Journal of general physiology · 2025
    Review
  7. Article
  8. The L-type calcium channel CaV1.3: A potential target for cancer therapy.Journal of cellular and molecular medicine · 2024
    Review
  9. A Novel De Novo Gain-of-FunctionNeurology. Genetics · 2024
    Article
  10. Pathogenicity of de novo CACNA1D CaEuropean journal of human genetics : EJHG · 2024
    Article
  11. Shared genetic basis connects smoking behaviors and bone health: insights from a genome-wide cross-trait analysis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Case Report: Clinical delineation ofFrontiers in neurology · 2023
    Article
  16. CACNA1D-Related Channelopathies: From Hypertension to Autism.Handbook of experimental pharmacology · 2023
    Review
  17. Impaired CaJournal of molecular and cellular cardiology · 2022
    Article
  18. Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 GeneInternational journal of molecular sciences · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nadja T Hofer1Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Petronel Tuluc1Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Nadine J Ortner1Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Yuliia V Nikonishyna1Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Monica L Fernándes-Quintero2Institute of General, Inorganic and Theoretical Chemistry, Centre for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Klaus R Liedl2Institute of General, Inorganic and Theoretical Chemistry, Centre for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Bernhard E Flucher3Division of Physiology, Department of Physiology and Medical Physics, Medical University Innsbruck, 6020 Innsbruck, Austria.
Helen CoxWest Midlands Regional Clinical Genetics Service, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, B15 2TG, Birmingham, UK.
Jörg Striessnig1Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.ORCID 0000-0002-9406-7120
Universität Innsbruck · ATInnsbruck Medical University · ATNational Health Service · GB

Funding

Austrian Science Fund FWF DOC 30Austrian Science Fund FWF P 27809Wellcome Trust
6 · The paper itself

Abstract

Background: There is increasing evidence that de novo Methods: For functional characterization, wild-type and mutant Cav1.3 channel complexes were expressed in tsA-201 cells and tested for typical gain-of-function gating changes using the whole-cell patch-clamp technique. Results: Mutation S652L significantly shifted the voltage-dependence of activation and steady-state inactivation to more negative potentials (~ 13-17 mV) and increased window currents at subthreshold voltages. Moreover, it slowed tail currents and increased Ca

Indexed as

Calcium Channels, L-TypeCalcium SignalingCell LineHumansModels, MolecularMutationNeurodevelopmental DisordersCACNA1D protein, humanCalcium Channels, L-TypeAutism spectrum disorderCACNA1DGain-of-function mutationL-type Ca2+-channelsNeurodevelopmental disorder

Identifiers

PMID31921405
PMCPMC6950833
OpenAlexW3003323971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.